Deep Track Capital, LP 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 08:43 am Sale |
2024-12-31 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 1,975,998 1.070% |
-13,946,657 (-87.59%) |
Filing |
| 2024-11-14 09:18 am Sale |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 15,922,655 8.650% |
-2,477,345 (-13.46%) |
Filing |
| 2024-02-14 08:50 am Purchase |
2023-12-31 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 18,400,000 9.650% |
6,097,763 (+49.57%) |
Filing |
| 2023-04-14 4:34 pm Purchase |
2023-04-04 | 13G | Nektar Therapeutics NKTR |
Deep Track Capital, LP | 12,302,237 6.500% |
12,302,237 (New Position) |
Filing |